International Journal of Vascular Medicine (Jan 2010)

Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach

  • M. B. I. Lobbes,
  • M. E. Kooi,
  • E. Lutgens,
  • A. W. Ruiters,
  • V. Lima Passos,
  • S. H. J. G. Braat,
  • M. Rousch,
  • H. Ten Cate,
  • J. M. A. van Engelshoven,
  • M. J. A. P. Daemen,
  • S. Heeneman

DOI
https://doi.org/10.1155/2010/726207
Journal volume & issue
Vol. 2010

Abstract

Read online

We evaluated leukocyte counts and levels of CRP, fibrinogen, MPO, and PAPP-A in patients with stable and unstable angina pectoris, acute myocardial infarction, and healthy controls. All biomarkers were analyzed again after 6 months. Leukocyte counts and concentrations of fibrinogen, CRP, MPO, and PAPP-A were significantly increased in patients with acute myocardial infarction. Leukocyte counts and concentrations of MPO were significantly increased in patients with unstable angina pectoris compared with controls. After 6 months, leukocyte counts and MPO concentrations were still increased in patients with acute myocardial infarction when compared to controls. Discriminant analysis showed that leukocyte counts, MPO, and PAPP-A concentrations classified study group designation for acute coronary events correctly in 83% of the cases. In conclusion, combined assessment of leukocyte counts, MPO, and PAPP-A was able to correctly classify acute coronary events, suggesting that this could be a promising panel for a multibiomarker approach to assess cardiovascular risk.